Report cards › Companies › Vertex Pharmaceuticals
Vertex Pharmaceuticals: Political money and lobbying (shown, not graded) records
Political money and lobbying (shown, not graded): 205 records from the U.S. Senate Office of Public Records (LDA.gov), from 2021 to 2026; 202 of them list an amount, $29,700,000 in all. Political money and lobbying (shown, not graded): 3 records from the Federal Election Commission, from 2022 to 2026; the amounts total $844,987. Outcomes as recorded: $415,487.00 to federal candidates' committees (2025-2026) (1), $231,000.00 to federal candidates' committees (2023-2024) (1), $198,500.00 to federal candidates' committees (2021-2022) (1).
Newest first; records 51 to 100 of 208. Each links to the agency's own record. Back to the report card.
| Date | Agency | What the agency recorded | Amount or outcome | Record | Retrieved | Matched | Report |
|---|---|---|---|---|---|---|---|
| Jan 13, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: HOLLAND & KNIGHT LLP reported $20,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2025 (4th Quarter - Report); issues TAX | $20,000 · $20,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 13, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VERTEX PHARMACEUTICALS INCORPORATED reported $1,110,000.00 (expenses) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2025 (4th Quarter - Report); issues BUD, HCR, MMM, PHA, TAX, TRD, VET; bills named: H.R. 6423, S. 864, H.R. 1227, S. 475, H.R. 1414 | $1,110,000 · $1,110,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CGCN GROUP, LLC reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2025 (3rd Quarter - Report); issues HCR, MMM; bills named: H.R. 1227, S. 475 | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: MCLARTY INBOUND LLC reported $90,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2025 (3rd Quarter - Report); issues TRD | $90,000 · $90,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: AVENUE SOLUTIONS reported $60,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2025 (3rd Quarter - Report); issues HCR, MMM; bills named: H.R. 1227, S. 475 | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TARPLIN, DOWNS & YOUNG, LLC reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2025 (3rd Quarter - Report); issues BUD, HCR, MMM | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STANTON PARK GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2025 (3rd Quarter - Report); issues HCR; bills named: H.R. 7142, S. 3832 | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: SALT POINT STRATEGIES reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS in the 3rd Quarter (July 1 - Sep 30) of 2025 (3rd Quarter - Report); issues PHA | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: MARSHALL & POPP, LLC reported $60,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2025 (3rd Quarter - Report); issues MMM; bills named: S. 475, H.R. 1227 | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 19, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TIBER CREEK GROUP reported $60,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS in the 3rd Quarter (July 1 - Sep 30) of 2025 (3rd Quarter - Report); issues DEF, HCR; bills named: H.R. 1227, S. 475, H.R. 3838, S. 2296 | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 19, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CROSSROADS STRATEGIES, LLC reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2025 (3rd Quarter - Report); issues HCR, MED, MMM; bills named: S. 475, H.R. 1227 | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 19, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: EMPIRE CONSULTING GROUP reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2025 (3rd Quarter - Report); issues HCR; bills named: H.R. 1227 | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 15, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: HOLLAND & KNIGHT LLP reported $20,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2025 (3rd Quarter - Report); issues TAX | $20,000 · $20,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 14, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VERTEX PHARMACEUTICALS INCORPORATED reported $1,110,000.00 (expenses) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2025 (3rd Quarter - Report); issues BUD, HCR, MMM, PHA, TAX, TRD; bills named: S. 864, H.R. 1227, S. 475, H.R. 1414 | $1,110,000 · $1,110,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 21, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: MARSHALL & POPP, LLC reported $60,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2025 (2nd Quarter - Report); issues MMM; bills named: S. 475, H.R. 1227, H.R. 1 | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 21, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TARPLIN, DOWNS & YOUNG, LLC reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2025 (2nd Quarter - Report); issues BUD, HCR, MMM | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 21, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: MCLARTY INBOUND LLC reported $90,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2025 (2nd Quarter - Report); issues TRD | $90,000 · $90,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 21, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STANTON PARK GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2025 (2nd Quarter - Report); issues HCR; bills named: H.R. 7142, S. 3832 | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 21, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: AVENUE SOLUTIONS reported $60,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2025 (2nd Quarter - Report); issues HCR, MMM; bills named: H.R. 1227, S. 475, H.R. 1672, H.R. 2484, H.R. 946, S. 1862, H.R. 1, H.Con.Res. 14 | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 21, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TIBER CREEK GROUP reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS in the 2nd Quarter (Apr 1 - June 30) of 2025 (2nd Quarter - Report); issues DEF, HCR; bills named: H.R. 1227, S. 475, H.R. 3838, S. 2296 | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 19, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CGCN GROUP, LLC reported $75,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2025 (2nd Quarter - Report); issues HCR, MMM; bills named: H.R. 1227, S. 475 | $75,000 · $75,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 19, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CROSSROADS STRATEGIES, LLC reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2025 (2nd Quarter - Report); issues HCR, MED, MMM; bills named: S. 475, H.R. 1227 | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 18, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: EMPIRE CONSULTING GROUP reported $40,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2025 (2nd Quarter - Report); issues HCR; bills named: H.R. 1227 | $40,000 · $40,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 16, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VERTEX PHARMACEUTICALS INCORPORATED reported $1,140,000.00 (expenses) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2025 (2nd Quarter - Report); issues BUD, HCR, MMM, PHA, TAX, TRD; bills named: S. 864, H.R. 1227, S. 475, H.R. 1414 | $1,140,000 · $1,140,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 16, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: SALT POINT STRATEGIES reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS in the 2nd Quarter (Apr 1 - June 30) of 2025 (2nd Quarter - Report); issues PHA | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 13, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: HOLLAND & KNIGHT LLP reported $20,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 2nd Quarter (Apr 1 - June 30) of 2025 (2nd Quarter - Report); issues TAX | $20,000 · $20,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 21, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STANTON PARK GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2025 (1st Quarter - Report); issues HCR; bills named: H.R. 7142, S. 3832 | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 21, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: AVENUE SOLUTIONS reported $60,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2025 (1st Quarter - Report); issues HCR, MMM; bills named: H.R. 1227, S. 475, H.R. 1672, H.R. 2484, H.R. 946, S. 891, H.R. 1968 | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 21, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CROSSROADS STRATEGIES, LLC reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2025 (1st Quarter - Report); issues HCR, MED, MMM; bills named: S. 475 | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 21, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: MARSHALL & POPP, LLC reported $40,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2025 (1st Quarter - Report); issues MMM; bills named: S. 475, H.R. 1227 | $40,000 · $40,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 20, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TARPLIN, DOWNS & YOUNG, LLC reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2025 (1st Quarter - Report); issues BUD, HCR, MMM | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 19, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CGCN GROUP, LLC reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2025 (1st Quarter - Report); issues HCR, MMM; bills named: H.R. 1227, S. 475 | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 19, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TIBER CREEK GROUP reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS in the 1st Quarter (Jan 1 - Mar 31) of 2025 (1st Quarter - Report); issues DEF, HCR; bills named: H.R. 7142, S. 3832 | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 19, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: SALT POINT STRATEGIES reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS in the 1st Quarter (Jan 1 - Mar 31) of 2025 (1st Quarter - Report); issues PHA | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 18, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: MCLARTY INBOUND LLC reported $20,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2025 (1st Quarter - Report); issues TRD | $20,000 · $20,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 18, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VERTEX PHARMACEUTICALS INCORPORATED reported $1,600,000.00 (expenses) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2025 (1st Quarter - Report); issues BUD, HCR, MMM, TAX; bills named: H.R. 1227, S. 475, S. 864 | $1,600,000 · $1,600,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 18, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: EMPIRE CONSULTING GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2025 (1st Quarter - Report); issues HCR; bills named: H.R. 1227 | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 12, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: HOLLAND & KNIGHT LLP reported $20,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 1st Quarter (Jan 1 - Mar 31) of 2025 (1st Quarter - Report); issues TAX | $20,000 · $20,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 21, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STANTON PARK GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2024 (4th Quarter - Report); issues HCR; bills named: H.R. 7142, S. 3832 | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 21, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: AVENUE SOLUTIONS reported $60,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2024 (4th Quarter - Report); issues HCR, MMM; bills named: H.R. 7142, S. 3832, S. 2973, H.R. 5378, S. 1339, H.R. 10545 | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 20, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CGCN GROUP, LLC reported $25,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2024 (4th Quarter - Report); issues HCR, MMM; bills named: H.R. 714, S. 3832 | $25,000 · $25,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 19, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TIBER CREEK GROUP reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS in the 4th Quarter (Oct 1 - Dec 31) of 2024 (4th Quarter - Report); issues HCR; bills named: H.R. 7142, S. 3832 | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 19, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CROSSROADS STRATEGIES, LLC reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2024 (4th Quarter - Report); issues HCR, MED, MMM; bills named: S. 3832, H.R. 7142 | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 19, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: HOLLAND & KNIGHT LLP reported $10,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2024 (4th Quarter - Report); issues TAX | $10,000 · $10,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 18, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: EMPIRE CONSULTING GROUP reported $50,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2024 (4th Quarter - Report); issues HCR; bills named: H.R. 7142, S. 127 | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 17, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VERTEX PHARMACEUTICALS INCORPORATED reported $970,000.00 (expenses) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2024 (4th Quarter - Report); issues HCR, MMM, TAX; bills named: H.R. 830, S. 1375, H.R. 7421, S. 3832 | $970,000 · $970,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 16, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: TARPLIN, DOWNS & YOUNG, LLC reported $80,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 4th Quarter (Oct 1 - Dec 31) of 2024 (4th Quarter - Report); issues BUD, HCR, MMM; bills named: H.R. 7142, S. 3838 | $80,000 · $80,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Dec 31, 2024 | Federal Election Commission | FEC: VERTEX PHARMACEUTICALS INCORPORATED POLITICAL ACTION COMMITTEE (VPAC) (committee C00468660; connected organization VERTEX PHARMACEUTICALS INCORPORATED) reported $231,000.00 in contributions to federal candidates' committees in the 2023-2024 cycle, reports through 2024-12-31 | $231,000 · $231,000.00 to federal candidates' committees (2023-2024) | Source record | Oct 24, 2026 | matched by name | Report an error |
| Oct 21, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: AVENUE SOLUTIONS reported $60,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2024 (3rd Quarter - Report); issues HCR, MMM; bills named: H.R. 7142, S. 3832, S. 2973, H.R. 5378, S. 1339 | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 21, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CROSSROADS STRATEGIES, LLC reported $30,000.00 (income) for lobbying for VERTEX PHARMACEUTICALS INCORPORATED in the 3rd Quarter (July 1 - Sep 30) of 2024 (3rd Quarter - Report); issues HCR, MED, MMM; bills named: S. 3832, H.R. 7142 | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
CSWH is not affiliated with these agencies.